Safety study of VNT-101 in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 59 years old.
- You have not smoked or used nicotine, tobacco, cannabis, or CBD products for at least 3 months (tobacco) or 60 days (cannabis).
- Your body mass index (BMI) is between 18 and 30.
- You have no major medical conditions, including heart disease, high blood pressure, or high cholesterol.
- Women must be unable to become pregnant (surgically sterilized or post-menopausal for at least 1 year). Men must use contraception or be sterilized.
- You have not taken any prescription medications in the last 14 days, and no over-the-counter drugs (except occasional acetaminophen) in the last 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
This study tests a new drug, RLX-2508-102, in healthy people to see how safe it is and how the body handles it. It's an early step to learn if the medicine could be used for future treatments.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This trial tests a new oral medication, called FB-101, in healthy adult men to see how safe it is and how the body processes it. Participation involves multiple visits and taking the drug in different doses.
This trial tests a new nasal spray (called LMN-1001) in healthy adults to see if it is safe and how the body handles it. It is an early-phase study, so the main goal is not to treat a disease but to check for safety and side effects.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.